Polyhydramnios

Clinical Obstetrics and Gynecology

Volumn 40, Issue 2, 1997, Pages 266-279

  Moise Jr , Kenneth J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; ARGIPRESSIN; BETA GLUCURONIDASE; CREATININE; DIGOXIN; DNA; FLECAINIDE; GENTAMICIN; GLUCOSE 6 PHOSPHATASE; HEMOGLOBIN A2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDOMETACIN; LIVER ENZYME; PROCAINAMIDE; PROPRANOLOL; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; QUINIDINE; SULINDAC; TRINUCLEOTIDE; VERAPAMIL;

AMNIOCENTESIS; AMNION FLUID; ARTICLE; DUCTUS ARTERIOSUS OBLITERATION; ECHOGRAPHY; FETUS HYDROPS; FETUS MALFORMATION; GASTROINTESTINAL SYMPTOM; HUMAN; HYDRAMNIOS; KARYOTYPE; KIDNEY FAILURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RECTAL DRUG ADMINISTRATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AMNIOCENTESIS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; INCIDENCE; INDOMETHACIN; POLYHYDRAMNIOS; PREGNANCY; RISK FACTORS; SULINDAC;

EID: 0343035697     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199706000-00004     Document Type: Article

References (65)

1. Litzenberg JC. Synopsis of Obstetrics. St. Louis: Mosby, 1941:225-238.
2. Chamberlain PF, Manning FA, Morrison I, Harman CR, Lange IR. Ultrasound evaluation of amniotic fluid volume. Am J Obstet Gynecol. 1984; 150:250-254.
3. Phelan JP, Smith CV, Bourssard P, et al. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation. J Reprod Med. 1987; 32:540-542.
4. Carlson DE, Platt LD, Medearis AL, et al. Quantifiable polyhydramnios: diagnosis and management. Obstet Gynecol. 1990; 75:989-993.
5. Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 1990; 162:1168-1173.
6. Chau AC, Kjos SL, Kovacs BW. Ultrasonographic measurement of amniotic fluid volume in normal diamniotic twin pregnancies. Am J Obstet Gynecol. 1996; 174:1003-1007.
7. Hill LM, Breckle R, Thomas ML, et al. Polyhydramnios: ultrasonically detected prevalence and neonatal outcome. Obstet Gynecol. 1987; 69:21-25.
8. Barnhart Y, Bar-Hava I, Divon MY. Is polyhydramnios in an ultrasonographically normal fetus an indication for genetic evaluation? Am J Obstet Gynecol. 1995; 173:1523-1527.
9. Ben-Chetrit A, Hochner-Celnikier D, Ron M, et al. Hydramnios in the third trimester of pregnancy: a change in the distribution of accompanying fetal anomalies as a result of early ultrasonographic prenatal diagnosis. Am J Obstet Gynecol. 1990; 162:1344-1345.
10. Landy HJ, Isada NB, Larsen JW. Genetic implications of idiopathic hydramnios. Am J Obstet Gynecol. 1987; 157:114 117.
11. Many A, Hill LM, Lazebnik N, et al. The association between polyhydramnios and preterm delivery. Obstet Gynecol. 1995; 86:389-391.
12. Golan A, Wolman I, Sagi J, et al. Persistence of polyhydramnios during pregnancy - its significance and correlation with maternal and fetal complications. Gynecol Obstet Invest. 1994; 37:18-20.
13. Hendricks SK, Conway L, Wang K, et al. Diagnosis of polyhydramnios in early gestation: indication for prenatal diagnosis? Prenat Diagn. 1991; 11:649-654.
14. Yankowitz J, Weiner CP, Henderson J, et al. Outcome of low-risk pregnancies with evidence of intraamniotic viral infection detected by PCR on amniotic fluid obtained at second trimester genetic amniocentesis. J Soc Gynecol Invest. 1996; 3:132A (Abstract).
15. Wendel GD, Maberry MC, Christmas JT, et al. Examination of amniotic fluid in diagnosing congenital syphilis with fetal death. Obstet Gynecol. 1989; 74:967-970.
16. Jensen ML, Rix M, Schroder HD, et al. Fetal akinesia-hypokinesia deformation sequence (FADS) in 2 siblings with congenital myotonic dystrophy. Clin Neuropath. 1995; 14:105-108.
17. Verspyck E, Mandelbrot L, Dommergues M, et al. Myastenia gravis with polyhydramnios in the fetus of an asymptomatic mother. Prenat Diagn. 1993; 13:539-542.
18. Stratton RJ, Patterson RM. DNA confirmation of congenital myotonic dystrophy in non-immune hydrops fetalis. Prenat Diagn. 1993; 13:1027-1030.
19. Brady K, Polzin WH, Kopelman JN, et al. Risk of chromosomal abnormalities in patients with idiopathic polyhydramnios. Obstet Gynecol. 1992; 79:234-238.
20. Schumacher B, Moise KJ. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol. 1996; 88:137-150.
21. Abramowicz J, Jaffe R, Altaras M et al. Fetal supraventricular tachycardia: prenatal diagnosis and pharmacological reversal of associated hydrops fetalis. Gynecol Obstet Invest. 1985; 20:109-112.
22. Moise KJ. Intrauterine transfusion with red cells and platelets. West J Med. 1993; 159:318-324.
23. Fairley CK, Smoleniec JS, Caul OE, et al. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet. 1995; 346:1335-1337.
24. Delia J, Enbery MG, Sheafor SA, et al. Twin transfusion syndrome: Successful in utero treatment with digoxin. Int J Gynaecol Obstet. 1985; 23:197-201.
25. Urig MA, Simpson GF, Elliot JP, et al. Twin-twin transfusion syndrome: the surgical removal of one twin as a treatment option. Fetal Ther. 1988; 3:185-188.
26. Wittman BK, Farquharson DF, Thomas WS. The role of feticide in the management of severe twin transfusion syndrome. Am J Obstet. 1986; 155:1023-1026.
27. Ville Y, Hyett J, Hecher K, et al. Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome. N Engl J Med. 1995; 332:224-227.
28. Hallack M, Moise KJ, Lira N, et al. The effect of tocolytic agents (indomethacin and terbutaline) on fetal breathing and body movements: a prospective, randomised, double blind, placebo-controlled clinical trial. Am J Obstet Gynecol. 1992; 167:1059-1063.
29. Stevenson KM, Lumbers ER. Effects of indomethacin on fetal renal function, renal and umbilicoplacental blood flow and lung liquid production. J Dev Physiol. 1992; 17:257-264.
30. Kirshon B, Moise KJ, Wasserstrum N, et al. Influence of short-term indomethacin therapy on fetal urine output. Obstet Gynecol. 1988; 72:51-53.
31. Mari G, Moise KJ, Deter RL, et al. Doppler assessment of the renal blood flow velocity waveform during indomethacin therapy for preterm labor and polyhydramnios. Obstet Gynecol. 1990; 75:199-201.
32. Anderson RJ, BerlT, McDonald KM, et al. Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest. 1975; 56:420-426.
33. Usberti M, Pecoraro C, Federico S, et al. Mechanism of action of indomethacin in tubular defects. Pediatrics. 1985; 75:501-507.
34. Mamopoulos M, Assimakopoulos E, Reece EA, et al. Maternal indomethacin therapy in the treatment of polyhydramnios. Am J Obstet Gynecol. 1990; 162:1225-1229.
35. Kirshon B, Mari G, Moise KJ. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Obstet Gynecol. 1090; 75:202-205.
36. Cabrol D, Landesman R, Muller J, et al. Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol. 1987; 157:422-426.
37. Lange IR, Harman CR, Ash KM, et al. Twin with hydramnios: treating premature labor at source. Am J Obstet Gynecol. 1989; 160:552-527.
38. Gerson A, Roberts N, Colmorgen G, et al. Treatment of polyhydramnios with indomethacin. Am J Perinatol. 1991; 8:97-98.
39. Rosen DJ, Rabinowitz R, Beyth Y, et al. Fetal urine production in normal twins and in twins with acute polyhydramnios. Fetal Diagn Ther. 1990; 5:57-60.
40. Ash K, Harman CR, Gritter H. TRAP sequence - successful outcome with indomethacin treatment. Obstet Gynecol. 1990; 76:960-962.
41. Malas HZ, Hamlett JD. Acute recurrent polyhydramnios - management with indomethacin. Br J Obstet Gynaecol. 1991; 98:583-587.
42. Restaino I, Kaplan BS, Kaplan P, et al. Renal dysgenesis in a monozygotic twin: Association with in utero exposure to indomethacin. Am J Med Genetics. 1991; 39:252-257.
43. Faber BL. Herhalende akute polihidramnios en indometasienbehandeling 'n gavalbespreking. S Afr Med J. 1990; 78:215-216.
44. Nordström L, Westgren M. Indomethacin treatment for polyhydramnios effective but potentially dangerous? Acta Obstet Gynecol Scand. 1992; 71:239-241.
45. Mohen D, Newnham JP, D'Orsogna L. Indomethacin for the treatment of polyhdramnios: a case of constriction of the ductus arteriosus. Aust N Z J Obstet Gynaecol. 1992; 32:243-246.
46. Dolhart LA, Eshwar KP, Reimers FT. Indomethacin therapy and chronic hemodialysis during pregnancy. A case report. J Reprod Med. 1992; 37:181-183.
47. Deeny M. Indomethacin use to control gross polyhydramnios complicating triplet pregnancy. Br J Obset Gynaecol. 1993; 100:281-282.
48. Carmona F, Martinez-Román S, Mortera C, et al. Efficacy and safety of indomethacin theray for polyhydramnios. Europ J Obstet Gynecol. 1993; 52:175-180.
49. Walker MP, Cantrell CJ. Maternal renal impairment after indomethacin tocolysis. J Perinatol. 1993; 13:461-463.
50. Vanhaesebrouck P, Thiery M, Vandewalle J, et al. Serum creatinine levels in preterm infants after intrauterine exposure to indomethacin. Med Sci Res. 1988; 16:93-94.
51. Mogilner BM, Ashkenazy M, Borenstein R, et al. Hydrops fetalis caused by maternal indomethacin treatment. Acta Obstet Gynecol Scand. 1982; 61:183-185.
52. Levin DL, Fixler DE, Morriss FC, et al. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr. 1978; 92:478-483.
53. Csaba IF, Sulyok E, Ertl T. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome. J Pediatr. 1978; 92:484.
54. Huhta JC, Moise KJ, Fisher DJ, et al. Detection and quantitation of constriction of the fetal ductus arteriosus by Doppler echocardiography. Circulation. 1987; 75:406-412.
55. Moise KJ, Huhta JC, Sharif DS, et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med. 1988; 319:327-331.
56. Van den Veyver I, Moise KJ, Ou C-N, et al. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the ductus arteriosus. Obstet Gynecol. 1993; 82:500-503.
57. Kirshon B, Mari G, Moise KJ, et al. Effect of indomethacin on the fetal ductus arterious during treatment of symptomatic polyhydramnios. J Reprod Med. 1990; 35:529-532.
58. Tulzer G, Gudmundsson S, Sharkey AM, et al. Doppler echocardiography of fetal ductus arteriosus constriction versus increased right ventricular output. J Am Coll Cardiol. 191; 18:532-536.
59. Vanhaesebrouck P, Thiery M, Leroy JG, et al. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr. 1988; 113:738-743.
60. Majors CA, Lewis DF, Harding JA, et al. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low birthweight infant. Am J Obstet Gynecol. 1994; 170:102-106.
61. Sibony O, De Gayffier A, Carbillon L, et al. Has the use of indomethacin during pregnancy consequences in newborn infants? Prospective study of 83 pregnant women and 155 newborn infants. Arch Pediatr. 1994; 1:709-715.
62. Kramer WB, Saade GS, Ou C-N, et al. Placental transfer of sulindac and its active sulfide metabolite in humans. Am J Obstet Gynecol. 1995; 172:886-890.
63. Räsäen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol. 1995; 173:20-25.
64. Carlan SJ, O'Brien WF, O'Leary TD, et al. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gyencol. 1992; 79:223-228.
65. Kramer W, Saade O, Belfort M, et al. Randomized double-blind study comparing sulindac to terbutraline: fetal renal and amniotic fluid effects. J Soc Gynecol Invest. 1996; 3:244A (Abstract).